C the Signs is a UK-based healthcare technology company that provides an AI-powered clinical platform for cancer detection. The platform is integrated directly into primary care systems, where it assists clinicians in identifying patients at risk across more than 100 cancer types. By analysing over 1,000 validated data points, it delivers risk assessments in under 60 seconds and has demonstrated 99% sensitivity in real-world clinical settings.
The company was founded by NHS doctors and built from within the National Health Service. Its stated mission is to make early cancer detection a standard practice, guided by the NHS values of equity, access, and care. The platform is now used by over 10,000 healthcare professionals across more than 1,500 GP practices in the UK, and has contributed to the identification of over 70,000 patients with cancer at an early stage.
C the Signs operates at the intersection of artificial intelligence, clinical decision support, and medical data analysis. Its product is designed for use within the primary care and clinical oncology verticals, focusing on integrating seamlessly into existing healthcare workflows rather than requiring separate specialist referrals for initial risk assessment.
